Patent Assignment
Reel/Frame 061379/0067
Assignment of Assignor's Interest
Recorded: 2022-10-11
Pages: 11
Assignors
LÖNN, HANS ROLAND
Executed: 2015-02-21
PONTÉN, JOHN FRITIOF
Executed: 2015-02-18
AURELL, CARL-JOHAN
Executed: 2015-03-03
PO KARLSSON, STAFFAN
Executed: 2015-03-03
Assignee
ASTRAZENECA AB
SE-151 85, SÖDERTÄLJE, SWEDEN
Covered Properties
(9)
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 11, 2022
From: DOYLE, KEVIN; VAN DE POËL, AMANDA; JONES, GRAHAM; WATSON, DAVID
To: BIOFOCUS DPI LTD
Reel/Frame 061378/0992 →
Assignment of Assignor's Interest
Oct 11, 2022
From: BIOFOCUS DPI LTD
To: ASTRAZENECA AB
Reel/Frame 061379/0011 →
Assignment of Assignor's Interest
Oct 11, 2022
From: CONNOLLY, STEPHEN; SWALLOW, STEVEN
To: ASTRAZENECA UK LIMITED
Reel/Frame 061379/0027 →
Assignment of Assignor's Interest
Oct 11, 2022
From: ASTRAZENECA UK LIMITED
To: ASTRAZENECA AB
Reel/Frame 061379/0055 →
Second Lien Patent Security Agreement
Oct 19, 2022
From: INSMED INCORPORATED
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Reel/Frame 061727/0039 →
Patent Security Agreement
Oct 20, 2022
From: INSMED INCORPORATED
To: BIOPHARMA CREDIT PLC
Reel/Frame 061735/0875 →